Mastrobattista J M, Luntz M
Manhattan Eye, Ear and Throat Hospital, St. Luke's-Roosevelt Hospital, New York, New York, USA.
Surv Ophthalmol. 1996 Nov-Dec;41(3):193-213. doi: 10.1016/s0039-6257(96)80023-3.
Management of intraocular pressure remains the cornerstone of glaucoma treatment. Related medical and surgical practices involve increasing aqueous outflow or decreasing aqueous production. Filtration procedures that increase aqueous outflow are the first-line surgical defense in glaucoma. However, some cases of glaucoma are resistant to such treatment. In these cases, ciliary body ablation by various methods has had substantial success. Surgical manipulation of aqueous production has been used in glaucoma management since the turn of the century. Techniques have progressed markedly as technology has produced more discrete therapies designed to decrease aqueous production by destroying ciliary body epithelium. Over the past 90 years success has been achieved with a wide range of techniques, from surgical disinsertion of the ciliary body to recent laser and ultrasound techniques. With the development of more precise contact lasers and endoscopic visualization, side effects have been reduced and clinical success rates increased.
眼压管理仍然是青光眼治疗的基石。相关的医学和外科手术包括增加房水流出或减少房水生成。增加房水流出的滤过手术是青光眼的一线手术防御手段。然而,一些青光眼病例对此类治疗有抵抗性。在这些病例中,通过各种方法进行的睫状体消融取得了显著成功。自世纪之交以来,手术控制房水生成已被用于青光眼治疗。随着技术产生了更多旨在通过破坏睫状体上皮来减少房水生成的精确疗法,技术有了显著进步。在过去90年里,从睫状体手术分离到最近的激光和超声技术等一系列技术都取得了成功。随着更精确的接触式激光和内镜可视化技术的发展,副作用减少,临床成功率提高。